"Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry.

Coronavirus Disease 2019 (COVID-19) remains a global health crisis, despite the development and success of vaccines in certain countries. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, uses its spike protein to bind to the human cell surface receptor angiotensin-converting enzyme 2 (ACE2), which allows the ...
virus to enter the human body. Using our unique cell screening technology, we identified two ACE2-binding peptoid compounds and developed dimeric derivatives (ACE2P1D1 and ACE2P2D1) that effectively blocked spike protein-ACE2 interaction, resulting in the inhibition of SARS-CoV-2 pseudovirus entry into human cells. ACE2P1D1 and ACE2P2D1 also blocked infection by a D614G mutant pseudovirus. More importantly, these compounds do not decrease ACE2 expression nor its enzyme activity (which is important in normal blood pressure regulation), suggesting safe applicability in humans.
Mesh Terms:
Angiotensin-Converting Enzyme 2, COVID-19, COVID-19 Drug Treatment, Humans, MCF-7 Cells, Peptidyl-Dipeptidase A, Peptoids, Protein Binding, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Virus Internalization
Int J Mol Sci
Date: Aug. 20, 2021
Download Curated Data For This Publication
245928
Switch View:
  • Interactions 1